#gene editing
Oct 2026
2.72P Optimization of intramuscular administration and in-vivo monitoring of gene-editing therapy in Duchenne muscular dystrophy
O. Sener, F. Sage, E. Niks et al.
· Neuromuscular Disorders · 0 citations